Christopher John Kenney - Aug 23, 2021 Form 3 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
Chief Medical Officer
Signature
/s/ Cassandra Robinson Attorney-in-fact
Stock symbol
XENE
Transactions as of
Aug 23, 2021
Transactions value $
$0
Form type
3
Date filed
8/25/2021, 04:05 PM
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XENE No securities are beneficially owned. 0 Aug 23, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XENE No securities are beneficially owned. Aug 23, 2021 N/A $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.